Intracortical chondroma of the metacarpal bone: A case report

Abstract

BACKGROUND

Intracortical chondroma of the metacarpal bone which could be painful is an extremely rare condition and previously only one case has been reported. Due to the similar physical features and appearance on clinical imaging, it is difficult to differentiate between intracortical chondroma and osteoid osteoma. Therefore, pathological examination is usually required to establish a definite diagnosis, which is often carried out only after tumor removal. In this study, we describe a case of intracortical chondroma which developed in the metacarpal bone and demonstrate the utility of magnetic resonance imaging (MRI).

CASE SUMMARY

We present a case of a 40-year-old man with intracortical chondroma of the metacarpal bone who was strongly suspected of having a tumor, and it was confirmed using contrast-enhanced MRI and successfully treated with curettage. MRI performed before tumor removal revealed signal intensity similar to that of the nidus of an osteoid osteoma. However, no abnormal intensity was observed in the bone or soft tissues surrounding the tumor. Such abnormalities on images would indicate the presence of soft-tissue inflammation, which are characteristics of osteoid osteoma. Furthermore, contrast-enhanced imaging revealed no increased enhancement of the areas surrounding the tumor. This is the first report to describe the contrast-enhanced MRI features of intracortical chondroma. This may serve as a guide for clinicians when intracortical chondroma is suspected.

CONCLUSION

The contrast-enhanced MRI was useful for the differential diagnosis of intracortical chondroma.

Key Words: Chondroma; Metacarpal bone; Tumor; Cartilage; Osteoma; Case report

Core Tip: In the present report, we described a case of intracortical chondroma with pain which developed in the metacarpal bone. Our findings highlight the utility of magnetic resonance imaging for the differential diagnosis of intracortical chondroma. To the best of our knowledge, this is the first report to describe the contrast-enhanced magnetic resonance imaging features of intracortical chondroma. This may serve as a guide for clinicians when intracortical chondroma is suspected.

INTRODUCTION

Chondroma is a type of benign bone tumor composed of hyaline cartilage. Chondroma arising in the bone cortex is called intracortical chondroma, which is an extremely rare condition. This disorder demonstrates lucent lesion with surrounding sclerosis and is usually painful[1-8]. The radiographical and clinical features of intracortical chondroma resemble those of cortical osteoid osteoma. Osteoid osteoma is usually painful and represents approximately 5% of all primary bone tumors[6]. The painful and intracortical lucent lesions of intracortical chondroma appear almost identical to the nidus of osteoid osteoma in both clinical and imaging examinations, making the two conditions hard to differentiate[3,5]. To the best of our knowledge, there have been no case reports detailing the features of magnetic resonance imaging (MRI) studies, including contrast-enhanced imaging, in the context of intracortical chondroma. In the present report, we describe a case of intracortical chondroma which developed in the metacarpal bone and demonstrate the utility of MRI. As we present important information related to the differential diagnosis of intracortical chondroma, our findings highlight the situations in which intracortical chondroma should be considered and may serve as a guide for clinical assessment in such cases.

CASE PRESENTATION

Chief complaints

An otherwise healthy 40-year-old man presented with the primary complaint of pain in the left hand that persisted for 2 mo. The pain started intermittently without any injury and was most severe at night. He visited a local clinic, where he underwent plain radiography which revealed a tumor in the second metacarpal bone, and the patient was referred to our hospital.

History of present illness

He visited a local clinic, where he underwent plain radiography which revealed a tumor in the second metacarpal bone, and the patient was referred to our hospital.

History of past illness

He had no significant medical history.

Personal and family history

He was healthy without a personal or family history of tumors.

Physical examination

Physical examination revealed stiffness and tenderness over the dorsum of the second metacarpal bone.

Laboratory examinations

Measurements of routine laboratory examinations, including routine blood tests, routine urine tests, and blood biochemistry, were within normal levels. Blood biochemistry results demonstrated no obvious abnormalities.

Imaging examinations

Plain radiography results revealed cortical expansion and well-demarcated lucency in the shaft of the second metacarpal bone (Figure 1). Plain computed tomography (CT) results revealed a 4 mm lucency with surrounding sclerosis and central calcification in the cortical bone on the ulnar side of the second metacarpal bone (Figure 2). No pathological fractures were observed.

Figure 1 Radiographs obtained from a 40-year-old man who presented with pain in the left hand. A: Antero-posterior view; B: lateral view radiographs revealed intracortical lucency and cortical thickening of the second metacarpal bone were observed on plain radiographs.

Figure 2 Plain computed tomography images. A: Coronal view; B: Axial view images revealed a 4 mm, well-defined lytic lesion and intra-tumoral punctate calcification. The appearance of this lesion on computed tomography images is almost similar to that of osteoid osteoma.

The tumor exhibited a distinct margin on MRI (Figure 3) with low signal intensity on T1-weighted images and high signal intensity on T2-weighted and short tau inversion recovery images. Axial contrast-enhanced images revealed only the tumor margin to be enhanced. No abnormal intensity was detected in the bone marrow or soft tissues around the lesion.

Figure 3 Magnetic resonance imaging of the second metacarpal bone. A: Low signal intensity on axial T1-weighted images; B: High signal intensity on axial T2-weighted images; C: Axial contrast-enhanced magnetic resonance imaging. Only the tumor margin was enhanced; D: Coronal short tau inversion recovery magnetic resonance imaging.

FINAL DIAGNOSIS

Results of the histopathological analysis revealed multinucleated chondrocytes with minimal atypia, which is consistent with the characteristics of chondroma. The site of tumor development was within the cortical bone; hence, the condition was determined to be intracortical chondroma (Figure 4). The final diagnosis of the presented case is intracortical chondroma of the metacarpal bone.

Figure 4 Histopathological image of the tumor. Hypocellular, cytologically banal hyaline cartilage suggested chondroma and was located in the cortical bone. The sample was stained with hematoxylin-eosin and imaged at × 100 magnification.

TREATMENT

We suspect benign intracortical lesions according to these MRI features. Administration of non-steroidal anti-inflammatory drugs (NSAIDs) did not completely control the local pain; therefore, curettage of the lesion was performed (Figure 5).

Figure 5 Photograph of the intraoperative appearance of the second metacarpal bone. A: Before curettage, protrusion of cortical bone is revealed; B: After curettage, the lesion was completely embedded in the cortical bone.

OUTCOME AND FOLLOW-UP

The pain subsided following curettage, and in the 1 year since surgery, the patient has experienced a favorable course with no recurrence (Figure 6).

Figure 6 Postoperative plain radiographs obtained 1 year after treatment with no recurrence. A: Antero-posterior view; B: Lateral view.

DISCUSSION

When a patient presents with a solitary painful tumor of the cortical bone, the possibility of chondrosarcoma, chondroma, and osteoid osteoma must be considered. In the present case report, radiographic findings did not reveal endosteal scalloping or destruction of the cortical bone suggesting chondrosarcoma. Conversely, MRI demonstrated well-demarcated lucency without reactive signal change around the lesion, meaning that osteoid osteoma could be ruled out as the reactive signal change is a typical feature of osteoid osteoma.

Chondroma is classified according to the location as enchondroma (arising in the medullary cavity), periosteal chondroma (arising in the periosteum), or intracortical chondroma (arising in the bone cortex), with most cases of chondroma being categorized as enchondroma. Periosteal and intracortical chondromas commonly develop in the long bones of relatively young patients and are accompanied by pain.

Intracortical chondroma was first reported by Abdelwahab et al[1] in 1990. To the best of our knowledge, only 10 cases of intracortical chondroma have been reported in the literature[1-8] (Table 1). The average age of onset was 20 years (range, 5-45 years), and the sites of tumor development were over the shaft to the shaft ends in the tibia of four patients, femur of three, humerus of two, and metacarpal bone of only one patient.

Table 1 Summary of the eleven cases of intracortical chondroma published to date.

Ref.	Age (yr)	Sex	Symptoms of pain	Analgesic effect of NSAIDs	Location	Tumor size (mm)	Radiology findings	Treatment		Recurrence
							Lucency with surrounding sclerosis	Cortical thickening	Calcification
Abdelwahab et al[1]	22	Male	+	NR	Femur	20	+	−	−	En bloc excision	−
Horikiri et al[2]	21	Male	+	NR	Metacarpal	12	+	−	−	En bloc excision and iliac bone graft	−
Ramnath et al[3]	5	Female	+	+	Tibia	5	+	+	−	CT-guided biopsy followed by radiofrequency ablation. After recurrence, en bloc excision	+ 6 mo after radiofrequency ablation
Ramnath et al[3]	7	Male	+	+	Femur	3	+	−	−	CT-guided biopsy followed by radiofrequency ablation	−
Lui et al[4]	7	Male	+	NR	Tibia	10	+	+	−	En bloc excision	−
Jones et al[5]	31	Female	+	NR	Humerus	8	+	+	−	Excisional biopsy	−
Jones et al[5]	41	Male	−	NR	Femur	10	+	－	−	Excisional biopsy	−
Choi et al[6]	12	Male	+	−	Tibia	5	+	+	−	Excisional biopsy	−
Chou et al[7]	7	Female	+	NR	Humerus	8	+	−	−	Excisional biopsy	−
Rudman et al[8]	45	Female	−	NR	Tibia	10	+	−	+	En bloc excision	−
Present case	40	Male	+	−	Metacarpal	4	+	−	+	Curettage	−

+: With; −: Without; NR: Not reported in the original study; CT: Computed tomography.

Removal of the tumor resulted in good outcomes with no recurrence for all but one patient in these previous studies. This one patient had undergone CT-guided tumor resection.

When the present case is included, pain symptoms were present in 9 of the 11 published cases. Pain relief was only achieved through the administration of NSAIDs in two cases. Osteoid osteoma is characterized by the efficacy of NSAIDs for pain relief and conservative treatment could be chosen[9]; therefore, this factor may be helpful for clinically distinguishing intracortical chondroma from osteoid osteoma. However, not all patients improve, and pain relief is achieved in 70% of osteoid osteoma patients[10] and both intracortical chondroma and osteoid osteoma are generally treated by complete resection with curettage.

In all cases, plain radiography and CT imaging revealed a lucency with surrounding sclerosis. Four cases showed the expansion of the cortical bone with cortical thickening around the tumor, which is often observed in the osteoid osteoma[3-6]. The present case as well as the one previous case showed central calcification-like osteoid osteoma[8]. These findings of clinical presentation and plain radiography and CT imaging highlight the importance of distinguishing intracortical chondroma from osteoid osteoma. Previous studies have supported the difficulty of this owing to the similar clinical and imaging findings, and it has been suggested that pathological examination is required to make a definitive diagnosis[1].

On MRI scans, osteoid osteoma is identified by an abnormal intensity of the tumor and reactive signal change around, the tumor and enhancement of intensity is a characteristic feature of osteoid osteoma owing to the presence of soft-tissue swelling and inflammation[10,11]. There is only one report in the literature on intracortical chordoma that included MRI findings. They reported the MRI fast-spin-echo sequence (TR3616, TE 28) coronal images of intracortical chondroma, revealing high signal intensity and circular lesions[5].

In the present report, we demonstrated a thin peripheral enhancement of the tumor, which some enchondromas might show[10], and the lack of signal change around the tumor on T1- or T2-weighted or enhanced images. Since imaging findings of intracortical chondroma and osteoid osteoma are similar, these findings demonstrate the notable differences and support the utility of MRI for differential diagnosis (Table 2). To the best of our knowledge, there have been no studies on intracortical chondroma demonstrating the features of signal intensity of both the tumor and the surrounding area by contrast-enhanced MRI; further studies are required into this analysis. Although clinical analyses and radiographic and CT imaging features appear to indicate osteoid osteoma in the bone cortex, on MRI, no signal change in the area surrounding the tumor would suggest intracortical chondroma.

Table 2 Clinical and imaging findings of intracortical chondroma and osteoid osteoma.

	Symptoms of pain	Analgesic effect of NSAIDs	Radiology findings			Contrast-enhanced magnetic resonance imaging
			Lucency with surrounding sclerosis	Cortica; thickening	Calcification
Intracortical chordoma	+	(-)-(+)	+	(-)-(+)	(-)-(+)	Only the tumor margin is enhanced
Osteoid osteoma	+	+	+	+	+	Signal intensity of both the tumor and the surrounding area

+: With; −: Without; NSAIDs: Non-steroidal anti-inflammatory drugs.

CONCLUSION

MRI was useful for the differential diagnosis of intracortical chondroma. To the best of our knowledge, this is the first report to describe the contrast-enhanced MRI features of intracortical enchondroma. This may serve as a guide for clinicians when intracortical chondroma is suspected.